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Abstract
Background: The Senegalese National Malaria Control Programme has recommended use of rapid diagnostic tests
(RDTs) that target the histidine-rich protein 2 (HRP2), specific to Plasmodium falciparum, to diagnose malaria cases.
The target antigen has been shown to be polymorphic, which may explain the variability in HRP2-based RDT results
reported in field studies. The genetic diversity of the pfhrp2 gene has not been investigated in depth in many
African countries. The goal of this study is to determine the extent of polymorphism in pfhrp2 among Senegal, Mali
and Uganda parasite populations, and discuss the implications of these findings on the utility of RDTs that are
based on HRP2 detection.
Methods: Sequencing data from the pfhrp2 locus were used to analyze the genetic diversity of this gene among
three populations, with different transmission dynamics and malaria parasite ecologies. Nucleotide diversity (π) and
non-synonymous nucleotide diversity (πNS) were studied in the pfhrp2 gene from isolates obtained in Senegal.
Amino acid repeat length polymorphisms in the PfHRP2 antigen were characterized and parameters of genetic
diversity, such as frequency and correlation between repeats in these populations, were assessed.
Results: The diversity survey of the pfhrp2 gene identified 29 SNPs as well as insertion and deletion polymorphisms
within a 918 bp region. The Senegal pfhrp2 exhibited a substantial level of diversity [π=0.00559 and πNS= 0.014111
(πS= 0.0291627)], similar to several polymorphic genes, such as msp1, involved in immune responses, and the gene
encoding the SURFIN polymorphic antigen, which are surface exposed parasite proteins. Extensive repeat length
polymorphisms in PfHRP2, as well as similar patterns in the number, organization and the type of predicted amino
acid repeats were observed among the three populations, characterized by an occurrence of Type 2, Type 4 and
Type 7 repeats.
Conclusions: These results warrant deeper monitoring of the RDT target antigen diversity and emphasize that
development of other essential genes as a target for diagnostic tools is critical.
Keywords: Plasmodium falciparum, HRP2, Diversity, RDT, Senegal
Background
For over 50 years various strategies have been developed
to reduce the burden of Plasmodium falciparum, the
most virulent malaria species and the primary cause of
malaria-related mortality across the globe [1]. Internatio-
nal funding programmes have first tasked the eradication
of this disease and, as a follow-up for regional elimination,
have provided tools such as insecticide-treated bed nets
(ITNs), indoor residual spraying (IRS), artemisinin-based
combination therapy (ACT), and rapid diagnostic tests
(RDTs) to many malaria-endemic regions. This report fo-
cuses on the implications of genetic diversity in the pfhrp2
gene that may compromise the use of RDTs for the diag-
nosis of malaria.
In 2006, the Senegalese National Malaria Control Pro-
gramme (NMCP) scaled up the use of malaria RDTs at
all health facilities in Senegal for case management [2]
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malaria infections, as misdiagnosis of malaria can con-
tribute to drug resistance [3]. The number of RDTs cur-
rently used in Senegal is between 900,000 and 1,200,000
annually [4]. RDTs are ideal for rural conditions in de-
veloping countries where well-equipped health facilities
and expert microscopists are lacking, as they give rapid
results, require no electrical equipment or temperature-
sensitive reagents, and can be performed without exten-
sive training. The technical performance of these tests
has been described previously [5], and although they are
sensitive and specific to detect most cases of malaria at
parasitaemia greater than 200 parasites/μl, product per-
formance can vary widely at low parasitaemia [6], and
these tools may miss individuals harbouring a very low
parasitaemia.
RDTs differ in the antigens they detect. Some are based
on detection of the P. falciparum specific histidine-rich
protein-2 (PfHRP2), or P. falciparum specific lactate
dehydrogenase (PfLDH), while others recognize anti-
gens common to P. falciparum, Plasmodium vivax, Plas-
modium ovale, and Plasmodium malariae (pan-species
pLDH and aldolase) [7]. Plasmodium aldolase and lactate
dehydrogenase (pLDH) are highly conserved RDT targets,
[8,9] in contrast to the P. falciparum PfHRP2 which is
considered to be more variable [10,11]. In Senegal, HRP2-
based RDTs are most commonly used in health facilities
because of their previously demonstrated sensitivity and
specificity and because P. falciparum represents the major
Plasmodium species (more than 98%) in Senegal [12], with
P. malariae and P. ovale comprising less than 2% of ma-
laria cases, and no P. vivax (0%) observed in 2013 [4].
The pfhrp2 gene of the P. falciparum 3D7 is localized
on chromosome 8 (PF3D7_0831800, PlasmoDB Version
9.3) and contains two exons separated by an intron. The
first exon encodes a signal peptide and the second exon
contains a protein-export motif followed by specific
histidine-rich repeats, which have been described pre-
viously [10,11]. PfHRP2 is synthesized throughout the
asexual life cycle and in early sexual stages of P. falcip-
arum [13]. The protein is characterized by the presence
of a number of variable tandem repeats, each one named
with a Type based on the motif being repeated [10,11].
Specific amino acid repeats AHHAAD (Type 7), AHH
AHHAD (Type 2) have been described as possible epi-
topes targeted by the monoclonal antibodies used to
detect HRP2 in some RDTs [14]. Many studies of the
genetic diversity of this antigen show extensive variation
within isolates of the same country and between isolates
of different countries [10,11,15]. In Senegal, the genetic
diversity of the gene target by the RDT has not yet been
investigated in depth. The goal of this study is to deter-
mine the extent of genetic polymorphism in the pfhrp2
gene in a Senegalese population in comparison with two
other diverse African populations: Mali and Uganda. In-
deed, previous reports from Mali have indicated the loss
of the HRP2 locus from some parasites, and this study in-
vestigates whether changes in this locus among Senegalese
parasites may compromise the performance of the RDTs
so widely used for malaria diagnosis.
To accomplish this goal, the pfhrp2 gene was se-
quenced using patient samples from Senegal, and along
with available sequencing data from Mali and Uganda
(three endemic African countries with different malaria
ecologies and epidemiology), was used to assess the nu-
cleotide polymorphism as well as the distribution of spe-
cific PfHRP2 amino acid repeats.
Methods
Parasite isolates
Both the Ethics Committee of the Ministry of Health
in Senegal and the Institutional Review Board of the
Harvard School of Public Health approved this study.
Parasite isolates from Senegal used in this study were
collected from malaria febrile patients, after informed
consent, during the malaria transmission season (August-
December), from 2001 to 2010, at three health facili-
ties: Pikine, Thies and Velingara. Pikine, a suburban area
(approximately 15 km from Dakar) is classified as low
transmission area (<5 cases per 1,000 individuals). Thies
(70 km from Dakar), is a hypo-endemic urban site with an
average of five malaria cases per 1,000 people. For Pikine
and Thies, the entomological inoculation rate (EIR) is low
less than five infectious bites per year. Velingara (in the
south of Senegal, 565 km from Dakar) is a highly endemic
area, with the level of transmission approximately 21 mal-
aria cases per 1,000 people and the EIR around 100 to 300
infectious bites per year [16]. Overall, 54 Senegal isolates
were used in this study (ten isolates from Pikine, 40 iso-
lates from Thies and four isolates from Velingara).
Mali is a border country of Senegal. The samples used
in this study are from Bandiagara in central eastern Mali,
where malaria is endemic and the P. falciparum trans-
mission is intense with seasonal peaks in July-October
[1]. Uganda is located in East Africa and is highly en-
demic for malaria, which is the leading cause of morbid-
ity and mortality [17]. However, samples were collected
in Kampala, an urban centre in Uganda where malaria is
meso-endemic, arising perennially with peaks during the
two rainy seasons from August to December and from
February to June [17].
DNA extraction
Plasmodium falciparum isolates from Senegal were
culture-adapted and deposited at the MR4 reagent reposi-
tory. Genomic DNA was isolated, for sequencing,
using Qiagen reagents according to the manufacturer
instructions.
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Samples were determined to be monogenomic and gen-
etically distinct by a 24 single nucleotide polymorphism
(SNP) molecular barcode [18]. Genomic DNA was se-
quenced using Illumina Hi-Seq machines, aligned to the
3D7 reference assembly, and variants were identified using
previously described methods [19]. Using variant and in-
variant sites, the pfhrp2 gene coding sequence (spliced
CDS sequence) was reconstructed for each sample, insert-
ing an ‘N’ to represent an undetermined base for sites that
could not be resolved due to insufficient sequence cover-
age. The SNP calls for the Uganda and Mali isolates are
downloadable from the Broad website [20].
Two isolates from Senegal SenT113.09 and SenV042.05
were PCR re-sequenced across the pfhrp2 region to con-
firm a frameshift mutation identified with GATK software
analysis of the sequence data (Additional file 1). Primers
specific to pfhrp2 amplifying the frameshift position
(nucleotides position 571 and 574 of SenT113.09 and
SenV042.05 respectively) were designed (Forward: GCA
CGCCGTTTTTGCCTCCGTACT and Reverse: GCACG
CAATGTGTGGCGGCTTC). PCR amplification was car-
ried out in a final reaction volume of 30 μlc o n t a i n i n g
DNA template (100 ng), primers (50 μM for each primer),
dNTPs (10 mM for each dNTP), and 0.6 μl Polymerase
(Pfu Ultra II Fusion polymerase, Agilent Technologies,
Inc). PCR amplification conditions were: denaturation at
95°C for 2 min, followed by 35 cycles of 95°C for 25 sec,
55°C for 25 sec and 60°C for 90 sec, with a final extension
phase at 72°C for 10 min. Quality control of PCR reactions
was performed by gel electrophoresis. PCR products were
purified with Qiagen columns and sequenced in both the
forward and reverse directions using the same PCR
primers as were used for the amplification. DNA sequen-
cing was performed by GENEWIZ [21] and amino-acid
sequences were deduced from the nucleotide sequences
obtained using TRANSEQ [22]. Nucleotide and amino
acid sequences were aligned with the 3D7 reference se-
quence (PlasmoDB MAL7P1.231) using Bio Edit Sequence
Alignment Editor Software (version 7.1.3.0). Polymorphic
repeats were characterized as described [15].
Nucleotide diversity
The genetic diversity of the pfhrp2 gene was measured
for the Senegal population (n= 54) using the nucleotide
diversity (π), which quantifies the average number of
nucleotide differences per site between DNA sequen-
ces among the sample population; and the πNS and πS
(non-synonymous and synonymous polymorphism, res-
pectively) values were calculated by dividing the average
number of non-synonymous or synonymous pairwise dif-
ferences by the number of non-synonymous or synony-
mous sites computed for all genes in the P. falciparum
genome (Additional file 2) [23]. For Mali (n=11) and
Uganda (n=9) isolates, DnaSp [24] was used to predict
nucleotide diversity (π) due to a smaller than ideal sample
size for estimating SNP diversity.
Statistical analysis
Differences in the median number of each type of amino
acid repeat were tested by Kruskall-Wallis for Senegal,
Mali and Uganda pfhrp2 sequences for each individual
repeat (α=0.05). The Spearman rank test was used to
evaluate the correlation between pairs of repeats in a
given population. For all statistical tests a significance
threshold of α = 0.05 was used.
Results
Analysis of the nucleotide diversity in the pfhrp2 gene
A total of 67 polymorphic sites among the 74 isolates
were identified, with 29 of these polymorphisms de-
scribed as “singletons”, appearing only in one isolate, ten
as “doubletons” found in two samples, and 28 as “multi-
ples” that appear in at least in three or more samples
(Additional file 1). The full-length CDS of the pfhrp2
gene ranges from 900 to 921 bp, and sequences were
aligned using Clustal W (Additional file 3). Polymor-
phisms in the pfhrp2 sequence from the three countries
include: 35 synonymous and 20 non-synonymous SNP po-
sitions, as well as 11 insertion-deletions (indels) (Figure 1).
For all defined populations, synonymous SNPs are more
common than non-synonymous SNPs (Figure 1), and
Figure 1 Frequency of polymorphism occurrence in the pfhrp2
gene from Senegal, Mali, and Uganda isolates. Non-synonymous,
synonymous, coding indels polymorphisms were observed.
Synonymous and non-synonymous SNPs are the more common
polymorphism in the three populations. Synonymous SNPs are higher
than non-synonymous SNPs, showing variability between countries.
Intronic indels and coding insertion were not observed in Mali.
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and inter-variability between isolates.
Of the 11 indels called by sequencing data, seven are
predicted to result in insertions or deletions of entire co-
dons (i.e. a multiple of three bp), two are intronic and
two are suggestive of frameshifts within the coding se-
quence. The two frameshifting indels are both singletons
and existed only in isolates SenT113.09 (insertion of two
nucleotides) and SenV042.05 (deletion of two nucleo-
tides). To confirm these frameshifts, the two isolates
were PCR re-sequenced (with the new sequences being
named SenT113.1.09 and SenV042.1.05). The amplification
of genomic DNA by primers surrounding polymorphic
amino acid (aa) positions 571 and 574, gave an amplicon
of approximately 900 bp in length. The alignment of
the translated PfHRP2 protein (Figure 2) revealed an
identity between the new sequences SenT113.1.09 and
SenV042.1.05 (79.7 and 91.1%, respectively) with the
3D7 reference, and the lack of any frameshift, suggesting
that errors in Illumina sequencing or GATK’s Unified
Genotyper produced a false call in these two cases. Conse-
quently, the effects of the two frameshifting indels were
ignored in further analysis.
The nucleotide diversity (π) and πNS diversity of the
pfhrp2 gene were then studied in depth among Senegalese
isolates to investigate whether pfhrp2 was remarkable in
this population, since at a protein level a high πNS may
affect the PfHRP2 protein detection. Thus, pfhrp2 π
and πNS were compared to other genes in the P. fal-
ciparum genome. As a point of reference, housekeeping
B
A
Figure 2 PCR re-sequencing. To confirm the frameshifting polymorphisms in isolates SenTh113.09 and SenV042.05, PCR amplification and
re-sequencing of the region surrounding the polymorphic positions corresponding to aa571 and aa574 in the coding sequence were performed.
A: Alignment of the re-sequenced SenV042.1.05 PfHRP2 sequences with 3D7 isolate. The two sequences share 91.1% identity. B: Alignment of the
re-sequenced SenTh113.1.09 PfHRP2 sequence with 3D7 isolate showed 79.7% identity. These results suggest that errors in Illumina sequencing
or GATK’s Unified Genotyper produced a false call in these two cases.
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cleotide diversity π=0.000 and πNS=0.00 0 (F igure 3) .
The nucleotide diversity for pfhrp2 is π= 0.00559, falling
near highly polymorphic genes such as merozoite surface
proteins (msp6, msp1, π>0.007) (Figure 3A). The distri-
bution of πNS varies widely in frequency among P. fal-
ciparum genes (Figure 3B, Additional file 2) and 89%
of P. falciparum g e n e sh a v eal o w e rπNS than pfhrp2.
The πNS=0 .0 14 1 ( πS =0.0291627) for pfhrp2 is simi-
lar to several genes encoding SURFIN antigens (PF3D7_
0800700) involved in cyto-adherence (πNS= 0.014065) and
a glycophorin binding protein family (PF3D7_1401000)
(πNS= 0.01574).
For Mali (n =11) and Uganda (n =9) isolates, the
predicted nucleotide diversity for pfhrp2 using DnaSp,
revealed π =5.76×10
-3 and π =1.065×10
-2 for Mali
and Uganda, respectively, which were both greater than
Senegal pfhrp2 (π=0.00559).
Analysis of the PfHRP2 amino acid repeat polymorphisms
The length of the PfHRP2 for the reference strain 3D7 is
305 amino acids. Amino acid sequences were deduced
from the nucleotide sequences and aligned using BioEdit
(Clustal W). Variations in the length of the PfHRP2 se-
quences were observed. These fragments ranged in size
from 299–307 aa (Additional file 4), with an average
length of 303 aas.
The PfHRP2 protein is composed of a varying number
of amino acids repeats [15]. The motif VLSAAVFAS
VLLLDNNNSAFNNNL (termed Type 0), is conserved
in all Senegalese, Malian and Ugandan PfHRP2 se-
quences (Table 1). In this study, 13 of the 20 different
A
B
Figure 3 Nucleotide diversity (π) and non-synonymous polymorphism (πNS). A: Comparison of the nucleotide (π)o fpfhrp2 in the
Senegalese population, to other P. falciparum genes. All π values were rank in the P. falciparum genome π=0.0000 to π= 0.07. The diversity π
pfhrp2= 0.00559 for Senegal falls within regions containing polymorphic genes such as msp1 or msp6. B: The non-synonymous polymorphism
(πNS= 0.014111) for pfhrp2 gene showed that 89% of genes have a lower πNS than pfhrp2.
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(Table 1) [10,15]. PfHRP2 sequences begin with the Type
1 (AHHAHHVAD) motif and end with the Type 12
(AHHAAAHHEAATH) motif (Additional file 4). The
frequency distributions of PfHRP2 type repeats within
the three African populations show an overall significant
difference in the median number of occurrences of the
different repeat types for each of the three populations
(Kruskall-Wallis, p<0.0001) (Figure 4). The frequencies
of Type 4 and Type 7 repeats, repeats thought to be the
targets of RDTs, were significantly different between the
three populations (Figure 4) (Kruskall-Wallis, p=0.0067,
p= 0.0287, respectively) suggesting that the frequency
and distribution of amino acid repeats could possibly re-
flect population level variation in the PfHRP2 protein.
The overall frequency of the Type 2, Type 4 and Type
7 repeats were compared to other regions of PfHRP2.
The Type 2 (range 0–11), Type 4 (range 0–17) and Type
7( r a n g e0 –8) were among the more variable repeats
that also had the highest frequencies in this study for
Senegal, Mali and Uganda (Figure 3 and Additional file 5).
The other repeat types showed lower frequencies (range
0–3). Similar results were reported in other studies [11,25]
where the Type 2 (range 2–14) and Type 7 (range 0–4)
were the most frequent types observed compared to other
repeat types [25].
Senegal isolates lack Type 11 and Type 14 repeats, as
do Mali and Uganda isolates. However, 5.5% of Senegal
isolates have the Type 9 repeat, which is absent from
Mali and Uganda samples. The Type 13 was not ob-
served in Mali isolates and one isolate from both Senegal
and Uganda contained this motif (Table 1). Similarly,
while the Type 5 repeat is absent in Uganda isolates, it is
present in 37.07% of Senegal samples and in 18.18% of
Mali samples (Table 1, Figure 3).
In addition to the frequency of the repeats, a diffe-
rence in the organization of the repeats in the PfHRP2
sequences was observed. Some Types are always found in
the same position in the protein: Type 3 (AHHAHHAAY)
at aa168-176; Type 5 (AHHAHHASD) at aa177-185; Type
8 (AHHAAY) at aa192-197; Type 9 (AAY) at aa192-197;
and, Type 12 (AHHAAAHHEAATH) at aa289-301.
Others motifs such as Type 1 (AHHAHHVAD), Type 2
(AHHAHHAAD), Type 4 (AHH) and Type 10 (AHHA
AAHHATD) can be present in clusters of two, three or
five copies and are distributed throughout the protein
(Additional file 4). When present, Type 1 and Type 10
motifs are found with at least two copies that are always
repeated in tandem, at aa57-83 and aa267-aa288, respect-
ively. Interestingly, the extent of Type 2 tandem repeats
varies between isolates, and can be observed as a cluster
of tandem repeats, or smaller clusters separated by other
Table 1 The frequency of amino-acid repeats of PfHRP2
Types Repeat found in the HRP2
sequence
Repeat frequency in
Senegal isolates N=54
Repeat frequency in
Mali isolates N=11
Repeat frequency in
Uganda isolates N=9
0 VLSAAVFASVLLLDNNNSAFNNNL 54 (100%) 11 (100%) 9 (100%)
1 AHHAHHVAD 52 (96.29%) 11 (100%) 9 (100%)
2 AHHAHHAAD 51 (94.4%) 11 (100%) 9 (100%)
3 AHHAHHAAY 29 (53.7%) 5 (45.45%) 7 (78%)
4 AHH 52 (96.29%) 11 (100%) 9 (100%)
5 AHHAHHASD 20 (37.07%) 2 (18.18%) 0%
6 AHHATD 45 (83.33%) 10 (90.9%) 9 (100%)
7 AHHAAD 51 (94.44%) 11 (100%) 9 (100%)
8 AHHAAY 37 (68.51%) 8 (72.72%) 9 (100%)
9 AAY 3 (5.55%) 0% 0%
10 AHHAAAHHATD 33 (61.1%) 6 (54.54%) 9 (100%)
11 AHN 0% 0% 0%
12 AHHAAAHHEAATH 40 (74.07%) 7 (63.63%) 9 (100%)
13 AHHASD 1 (1.85%) 0% 1 (11%)
14 AHHAHHATD 0% 0% 0%
19 AHHAA 43 (79.62%) 11 (100%) 8 (88.88%)
20 SHHD 0% 0% 0%
21 AHHAHHATY 0% 0% 0%
22 AHHAHHAGD 0% 0% 0%
23 ARHAAD 0% 0% 0%
24 AHHTHHAAD 0% 0% 0%
Repeat Types found in Senegal, Mali, and Uganda isolates. Repeat Types found in 100% of isolates are in bold, 0% and other percentages are in plain text.
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usually at position aa75-80, but is also found at other
positions in the protein. The Type 6 repeat (AHHATD)
most often occurs in three positions (aa213-218; aa237-
242; aa252-257) while Type 7 (AHHAAD) and Type 19
(AHHAA) are widely dispersed in PfHRP2.
In addition to variation between populations in repeat
structure and frequency, there was a significant correl-
ation between repeat Type 1-Type 2 and Type 3-Type 5
(rs=0.6158 P<0.0001, rs=0.5151 P<0.0001, respectively;
Bonferroni correction P <1.84 10
-4)i nt h eS e n e g a l e s e
PfHRP2 sequences. For Mali PfHRP2 Types repeats, a
significant correlation was observed between repeat Type
10-Type 19 (rs=−0.8945, P<0.0001). No significant cor-
relation was observed in repeat types from among
Ugandan sequences, possibly due to the small sample
size in Uganda (n=9) which makes statistical inter-
pretation more challenging (Table 2).
Discussion
Plasmodium falciparum tests targeting the PfHRP2 anti-
gen have demonstrated high detection rates [26], how-
ever test performance showed variability between lots
and between similar products. Recently P. falciparum
genetic factors have been investigated as a possible cause
of variability in RDT detection rates [15,25,27]. As gene-
tic diversity in P. falciparum is associated with transmis-
sion intensity, such findings could significantly interfere
with the ability to accurately detect all malaria cases,
and therefore have great potential to impact control
strategies and efforts to eliminate or eradicate the dis-
ease [28]. For this reason, it has become increasingly im-
portant to characterize the diversity of target antigens
used in RDTs to predict the impact genetic variation has
on diagnosis, since it has the potential to affect the sen-
sitivity of these diagnostic tests. In this study, the genetic
diversity (π and πNS) in the pfhrp2 gene was described
Figure 4 Variation in the number of types repeats. Differences in the median number of repeats of each type are shown. There is a
significant difference in the median of the Type 4 repeat (P value=0.0067) and the Type 7 repeat (P value=0.0287) within the three African
populations (S: Senegal, M: Mali, U: Uganda) of P. falciparum; P value <0.0001). Population comparison using Kruskall Wallis in a non-parametric
way shows a significant difference in the median number of the Type 4 and the Type 7 repeats. The frequency and distribution of amino acids
repeats shows inter and intra-species variation in the PfHRP2 sequence.
Table 2 Correlations found between repeat types
Country Type repeats correlated rs P value
Senegal Type 1 vs Type 2 0.6158 < 0.0001
Type 3 vs Type 5 0.5151 < 0.0001
Mali Type 10 vs Type 19 − 0.8945 < 0.0001
Uganda No statistical correlation found
Spearman rank analysis was performed on all pairs of repeat motifs in a given
population. The Bonferroni correction was applied. The total number of tests is
n = 273 for the three populations and for all statistical tests α = 0.05, given a
threshold P <1.83 × 10
-4. Significant correlations are listed. (vs: versus, rs:
Spearman rank).
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sites obtained from human infections in three African
countries with distinct patterns of malaria transmission
were analyzed, to provide additional information about
the diversity of this locus to that described previously
[10,11,25].
Here, the global nucleotide diversity π values calcu-
lated for pfhrp2 in the Senegal, Mali and Uganda isolates
are similar to highly polymorphic genes families exposed
to strong immune pressure, such as msp1 and msp6,
since these genes are highly polymorphic [29]. In addi-
tion, the πNS for the pfhrp2 is high, similar to πNS for
genes encoding the polymorphic SURFIN antigens ex-
pressed on P. falciparum merozoite and infected erythro-
cytes [30]. The pfhrp2 gene is located in the subtelomeric
region of chromosome 8 within a dynamic area where re-
combination events frequently contribute to the high ge-
netic variation observed among genes from these regions
[31]. In addition, the pfhrp2 gene reveals differential poly-
morphism by geography, with distinct population profiles
of synonymous and non-synonymous SNP variants, with
over half these variants being synonymous SNPs. This is
particularly important because non-synonymous SNP may
destabilize protein structure or interfere with either ligand
binding or the formation of domain-domain interfaces
[32] and these changes may affect the ability of monoclo-
nal antibodies to detect PfHRP2, thus compromising the
sensitivity of the RDT.
Insertions and deletions of nucleotides observed in this
study provided similar level of polymorphisms as SNPs
in pfhrp2. Previous studies have reported deletion of the
pfhrp2 gene associated with false-negative HRP2-based
RDTs in Mali, suggesting that spontaneous hrp2 dele-
tions could be one mechanism of genetic variation res-
ponsible for RDT failures [27]. Such deletions have been
reported before in South America, where 15/275 para-
sites (5.5%) were found with deletions of the pfhrp2
gene, generating concerns over the reliability of PfHRP2-
based RDTs in these regions [33]. Furthermore, genetic
deletions were not restricted to the pfhrp2 alone, but
were found to extend into neighbouring genes such as
Hsp70 (PF3D7F_0831700) in the 3’ region of pfhrp2
and in 5’ a pseudo-gene encoding a Plasmodium ex-
ported protein (PF3D7F_0831900) [34]. Such data em-
phasize the importance of precisely mapping deletions
in pfhrp2 in parasites from Senegal and other geographic
regions.
It is important to note that the genomic DNA samples
used in this study were obtained from culture-adapted P.
falciparum isolates (and additionally from single clone
infections). Further studies should focus on DNA obtained
directly from patients as many infections are polygenomic,
and also culturing parasites can lead to artifactual differ-
ences resulting from the process of culture adaptation,
such as breakage of P. falciparum chromosomes occurring
frequently in the pfhrp2, a subtelomeric gene [35]. How-
ever, the number of isolates was quite small for Mali and
Uganda to allow more stringent comparison. Nevertheless,
these findings suggest that the parasite differences based
upon different geography, and consequently ecology and
epidemiology, are important to consider.
At the amino acid level, the PfHRP2 protein showed
significant differences, in the organization and the num-
ber of repeats, likely due to chromosome breakage and
healing occurring randomly in a site-unspecific manner
during culture in vitro [35]. The composition of the
PfHRP2 sequence repeats in Senegalese isolates is si-
milar to Mali and Uganda isolates where the Type 2
(AHHAHHAAD), Type 4 (AHH) and the Type 7 (AHH
AAD) are the mostly common repeats (Table 1). The anti-
gen PfHRP2 differs in the composition and the num-
ber of repeat types compared to parasites from global
endemic countries previously reported [10,11,15]. Specif-
ically, Senegalese PfHRP2 isolates differ from Cameroon
isolates (presence of Type 11, and Type 14 repeats),
Thailand (presence of Type 14 repeat), Philippines (pre-
sence of Type 11 repeat), and Papua New Guinea (pre-
sence of Type 14 repeat). In this analysis Type 11 and
Type 14 repeats were not observed. Additionally, Type 20
(SHHDD), Type 21 (AHHAHHATY), Type 22 (AHHAH
HAGD), Type 23 (ARHAAD), and Type 24 (AHHTH
HAAD) repeats reported previously [10] were not found.
These results agree with previously published studies
[10,25], which found a high frequency of Type 2 and
Type 7 repeats. Ideally, for a universal and sensitive RDT,
the target epitope should be present in all parasites, re-
gardless of specific population, and should be present in
multiple copies [14]. For RDT sensitivity, a major factor is
the binding specificity and affinity of the monoclonal anti-
bodies for the target epitopes, thus the expression level
and number of these epitopes could potentially influence
the binding affinity. From these data and that of other
studies, the high frequency of Type 2, Type 4 and Type 7
repeats observed in P. falciparum isolates could contribute
to the sensitivity of the RDTs in the African populations
studied.
The study of the amino acid composition of the PfHRP2
protein showed that different factors can contribute to
polymorphism at the protein level: both the organiza-
tion of the repeats within sequences and the position
of repeats in the antigen. In fact, the frequency or
distribution of the target epitopes present in a par-
ticular parasite population may have an impact on the
efficiency of antigen detection in this population and
the sensitivity of RDTs [10,15]. These parameters should
be taken into account in the choice and the design of
monoclonal antibodies that could be used for PfHRP2
based RDTs.
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To counter increasing malaria drug resistance and to
achieve the goal of malaria eradication, the need for reli-
able diagnostic tools is critical. This study provides in-
formation about the genetic diversity of the pfhrp2 gene
and the predicted polymorphism in the PfHRP2 antigen
from sequences obtained from three African parasite
populations Senegal, Mali and Uganda. For all three po-
pulations of parasites, the higher rate of synonymous
SNPs in pfhrp2 suggests evolutionary selection of this
SNP. However, for Senegal isolates, the π and πNS war-
rant deeper follow-up investigations as they may re-
present functional variation, which would potentially
interfere with RDT detection. Pfhrp2 is polymorphic
at the nucleotide level, shown by both synonymous and
non-synonymous SNPs; nucleotide (π) and non syno-
nymous (πNS) diversity similar to highly polymorphic
genes such as msp1 and gene encoding SURFIN antigen.
PfHRP2 showed extensive repeat length polymorphisms
with an occurrence of the Type 2, Type 4 and Type 7
repeats. Similar patterns were observed in the number,
organization and the type of amino acid repeats in the
protein among the three African populations. However,
the PfHRP2 showed variation within isolates of the same
country and between isolates of different countries, ad-
dressing concern in the efficacy of the HRP2 based RDT
test. Since the polymorphism described in the target anti-
gen is a recognized concern, comprehensive studies of
possible factors influencing the sensitivity of these diag-
nostic tools, including genetic deletions and protein ex-
pression level, are critical in predicting the efficacy of
RDTs in global populations.
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Additional file 1: Polymorphic position in the pfhrp2 gene.
The positions of the SNPs identified are showed. The Table contains
i n f o r m a t i o na b o u tt h eS N Pt y p e s ,t h ed e s c r i p t i o no ft h eg e n ew h e r e
the SNP is located, the position of the SNPs, the possible alternative
alleles, the minor allele frequency, and the call rate. A total of 67
polymorphisms were identified, one per row, among Senegal, Mali
and Uganda isolates. These polymorphisms include SNPs and indels.
The indels position is reported as the position before the insertion/
deletion point, and the base before it is repeated. The first letter in
the isolate names indicates the site of collection (P for Pikine; V for
Velingara; and, T for Thies), and the last two digits in the isolate
names indicate the year of collection (e.g., P05.02 was isolated
in 2002).
Additional file 2: Nucleotide diversity synonymous and
non-synonymous polymorphism in Senegalese isolates. The Table
contains 5,495 P. falciparum genes from the set of Senegalese isolates.
Each line corresponds to a description of the gene with data on
localizations in the genome, the nucleotide diversity π, synonymous and
non-synonymous polymorphism (πS and πNS) and additionally the ratio
(πNS/πS).
Additional file 3: Alignment of pfhrp2 coding sequences from,
Senegal, Mali and Uganda isolates. All CDS were aligned Using BioEdit
software, with Clustal W program.
Additional file 4: Alignment of PfHRP2 sequence. All protein
sequences were aligned against the 3D7 reference, using BioEdit
software and Clustal W program.
Additional file 5: PfHRP2 Repeat Types. Thee table contains the
repeat Types found in the PfHRP2 sequence from Senegal, Mali and
Uganda isolates. Each line represents an isolate, with the number of the
different repeat Types observed within the sequences indicated.
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